Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

11.04.22	Pfizer Names David M. Denton Chief Financial Officer (Businesswire)
11.04.22	Additional definitive proxy soliciting materials and Rule 14(a)(12) material (RSS)
07.04.22	Pfizer To Acquire ReViral For Up To $525 Mln (RTTNews)
07.04.22	Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates (Businesswire)
07.04.22	Form SC 13D/A 78003 (RSS)
06.04.22	Form DEFA14A 78003 (RSS)
01.04.22	Form 4 78003 (RSS)
30.03.22	FDA Authorizes 2nd Booster Dose Of Pfizer, Moderna COVID-19 Vaccines (RTTNews)
30.03.22	Pfizer Announces Positive Results From Phase 3 Trial Of Etrasimod In Ulcerative Colitis (RTTNews)
30.03.22	Everest Medicines Announces that Licensing Partner Pfizer Reports Positive Topline Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients, Underscoring Best-in-Class Potential (PR Newswire)
29.03.22	FDA Gives Emergency Use Authorization To Pfizer's Second COVID-19 Booster Dose (RTTNews)
29.03.22	Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older (Businesswire)
29.03.22	Pfizer Reports Positive Top-line Results For Phase 3 Trial Of Etrasimod In Ulcerative Colitis (RTTNews)
29.03.22	Pfizer Announces Positive Top-line Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis, Underscoring Best-in-Class Potential (Businesswire)
28.03.22	Initial statement of beneficial ownership of securities (RSS)
25.03.22	ViiV Healthcare : FDA Approves Label Update For Long-acting HIV Treatment Cabenuva (RTTNews)
24.03.22	Pfizer Says FDA Grants Breakthrough Therapy Designation For RSV Vaccine Candidate (RTTNews)
24.03.22	Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Older Adults (Businesswire)
23.03.22	Pfizer Announces Positive Topline Results For Phase 3 Study Of Etrasimod For Ulcerative Colitis (RTTNews)
23.03.22	Pfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients (Businesswire)
22.03.22	Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts (Businesswire)
22.03.22	Pfizer To Supply UNICEF Up To 4 Mln Oral Courses Of Paxlovid To Fight Covid-19 In 95 Countries (RTTNews)
22.03.22	Pfizer Recalls Blood Pressure Drug Accuretic, Two Generics (RTTNews)
22.03.22	Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries (Businesswire)
17.03.22	Alnylam Files Patent Infringement Suits Against Pfizer And Moderna On COVID-19 Vaccines (RTTNews)
17.03.22	Additional definitive proxy soliciting materials and Rule 14(a)(12) material (RSS)
17.03.22	Form DEF 14A 78003 (RSS)
17.03.22	Form 4 78003 (RSS)
16.03.22	Pfizer Seeks Emergency Use Authorization In U.S. For Second COVID-19 Booster Dose (RTTNews)
15.03.22	Pfizer To Continue Supplying Medicines To Russia, Halts Clinical Trials (RTTNews)
14.03.22	IDEAYA, Pfizer To Evaluate Darovasertib- Crizotinib Combination In MUM And Addl CMET-Driven Tumors (RTTNews)
14.03.22	IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreements for Evaluation of Darovasertib and Crizotinib Combination in Metastatic Uveal Melanoma and Additional cMET-Driven Tumors (PR Newswire)
11.03.22	Pfizer Completes Acquisition of Arena Pharmaceuticals (Businesswire)
09.03.22	Pfizer Begins Phase 2/3 Study Of COVID-19 Oral Treatment In Pediatric Participants (RTTNews)
09.03.22	Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants (Businesswire)
08.03.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
02.03.22	FDA Grants Breakthrough Therapy Designation For Pfizer's RSVpreF To Prevent RSV In Infants (RTTNews)
01.03.22	Pfizer's Covid Vaccine Not Very Effective In Children Between 5-11 Years Against Omicron Variant (RTTNews)
01.03.22	Pfizer : Phase 3 Trial Of Investigational C. Difficile Vaccine Fails To Meet Primary Goal (RTTNews)
01.03.22	Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints (Businesswire)
28.02.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
25.02.22	Biohaven, Pfizer Get Positive CHMP Opinion For Rimegepant To Treat Migraine (RTTNews)
25.02.22	Form 4 78003 (RSS)
24.02.22	Form 10-K 78003 (RSS)
22.02.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Keynote Presentation at Healthcare Conference (Businesswire)
20.02.22	FDA Considers Approving Second COVID-19 Booster Dose: Report (RTTNews)
17.02.22	Form 4 78003 (RSS)
15.02.22	Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency (Businesswire)
15.02.22	European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults (Businesswire)
14.02.22	FDA Pushes Vaccine For Children Under 5 Year Back For More Data (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

16:22		Roche-Aktie verliert dennoch: Roche bringt neue Massenspektrometrie-Analysegeräte Cobas auf Markt
16:02		Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Verlust hätte ein Investment in Johnson Johnson von vor einem Jahr eingebracht
15:58		Optimismus in Frankfurt: SDAX am Nachmittag mit Zuschlägen
15:58		Gute Stimmung in London: FTSE 100 bewegt sich am Nachmittag im Plus
15:58		Anleger in Zürich halten sich zurück: SPI gibt nachmittags nach
15:58		STOXX 50 aktuell: STOXX 50 nachmittags mit Zuschlägen
15:58		Euro STOXX 50-Handel aktuell: Euro STOXX 50 am Nachmittag mit Gewinnen
15:58		Gute Stimmung in Frankfurt: Anleger lassen TecDAX steigen

16:22

Roche-Aktie verliert dennoch: Roche bringt neue Massenspektrometrie-Analysegeräte Cobas auf Markt

16:02

Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Verlust hätte ein Investment in Johnson Johnson von vor einem Jahr eingebracht

15:58

Optimismus in Frankfurt: SDAX am Nachmittag mit Zuschlägen

15:58

Gute Stimmung in London: FTSE 100 bewegt sich am Nachmittag im Plus

15:58

Anleger in Zürich halten sich zurück: SPI gibt nachmittags nach

15:58

STOXX 50 aktuell: STOXX 50 nachmittags mit Zuschlägen